Paul Aisen

发表

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

Machine learning for comprehensive forecasting of Alzheimer’s Disease progression

Jonathan R. Walsh, Aaron M. Smith, Charles K. Fisher, 2018, Scientific Reports.

ADCS data sharing

Paul Aisen, Ronald Thomas, Gustavo Jimenez, 2012, Alzheimer's & Dementia.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Andrew J. Saykin, Arthur W. Toga, Qianjin Feng, 2017, Scientific Reports.

Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

ADCS electronic data capture: Integrated image management

Stefania Bruschi, Gustavo Jimenez-Maggiora, Paul Aisen, 2013, Alzheimer's & Dementia.

GenEpi: gene-based epistasis discovery using machine learning

Michael W. Weiner, Yen-Jen Oyang, Arthur W. Toga, 2018, BMC Bioinformatics.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009

Oscar L. Lopez, Bruno Vellas, William R. Shankle, 2010, Alzheimer's & Dementia.

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features

Adrian Preda, Evan Fletcher, Charles DeCarli, 2017, Scientific Reports.

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Nature Communications.

Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force

Bruno Vellas, Harald Hampel, Philip Scheltens, 2013, Alzheimer's & Dementia.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Norbert Schuff, Robert C. Green, Andrew J. Saykin, 2017 .

Biological markers of amyloid β-related mechanisms in Alzheimer's disease

Harald Hampel, John Q. Trojanowski, Henrik Zetterberg, 2010, Experimental Neurology.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Norbert Schuff, Adrian Preda, John Kornak, 2012, Proceedings of the National Academy of Sciences.

Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2020, Scientific Reports.

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition

Michael Weiner, Prashanthi Vemuri, John Trojanowski, 2011, Alzheimer's & Dementia.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

Michael W. Weiner, Robert C. Green, Shannon L. Risacher, 2017, Scientific Reports.

HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer’s disease in a three cohorts study

Ronald C. Petersen, Robert Dufour, Paul Aisen, 2014, Molecular Psychiatry.

Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials.

Jeffrey Cummings, Rema Raman, Paul Aisen, 2012, Archives of neurology.

Early Indications of Future Cognitive Decline: Stable versus Declining Controls

Michael Weiner, Paul Aisen, Clifford Jack, 2013, PloS one.

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Scientific Reports.

P3-040: Alzheimer's disease neuroimaging initiative: Baseline characteristics

Ronald C. Petersen, Michael Weiner, Laurel Beckett, 2008, Alzheimer's & Dementia.

Large-scale genomics unveil polygenic architecture of human cortical surface area

Norbert Schuff, Anders M. Dale, Robert C. Green, 2015, Nature Communications.

The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding

Danielle J. Harvey, Paul Aisen, Michael C. Donohue, 2015, Alzheimer's & Dementia.

Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer’s disease

Veronique Bohbot, Clifford R. Jack, Alan C. Evans, 2015, Scientific Data.

Biomarkers for Alzheimer's disease therapeutic trials

Nick C. Fox, Michael Weiner, Giovanni B. Frisoni, 2011, Progress in Neurobiology.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2019, Scientific Reports.